Search results for "digestive system"

showing 10 items of 1747 documents

Aussagefähigkeit der Abdomenübersichtsaufnahme in der Differenzierung der Rotavirus-negativen und Rotavirus-positiven nekrotisierenden Enterokolitis

1991

Clinical data and radiographic findings of 32 newborn suffering from necrotising enterocolitis were analysed [12 patients with rotavirus-positive necrotising enterocolitis (RV + NEC), 20 patients with rotavirus-negative necrotising enterocolitis (RV-NEC)]. The presence and degree of pneumatosis intestinalis, portal venous gas and pneumoperitoneum on abdominal radiographs were graded after Kosloske et al. according to "mild, moderate, and severe". Pneumatosis intestinalis occurred twice as often in the ascending colon in RV-NEC compared to RV + NEC, whereas the transverse colon was involved nearly as frequently as the descending colon in both groups. Portal venous gas was present in 10% of t…

Pathologymedicine.medical_specialtybusiness.industryTransverse colonmedicine.diseasemedicine.disease_causedigestive system diseasesDescending colonmedicine.anatomical_structurePneumoperitoneumRotavirusPneumatosis Cystoides IntestinalisNecrotizing enterocolitismedicineAscending colonRadiology Nuclear Medicine and imagingmedicine.symptomPneumatosis intestinalisbusinessRöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren
researchProduct

Hepatitis C virus prevalence and level of intervention required to achieve the WHO targets for elimination in the European Union by 2030: a modelling…

2017

Background Hepatitis C virus (HCV) is a leading cause of liver-related morbidity and mortality worldwide. In the European Union (EU), treatment and cure of HCV with direct-acting antiviral therapies began in 2014. WHO targets are to achieve a 65% reduction in liver-related deaths, a 90% reduction of new viral hepatitis infections, and 90% of patients with viral hepatitis infections being diagnosed by 2030. This study assessed the prevalence of HCV in the EU and the level of intervention required to achieve WHO targets for HCV elimination. Methods We populated country Markov models for the 28 EU countries through a literature search of PubMed and Embase between Jan 1, 2000, and March 31, 201…

Pediatricsddc:616.07medicine.disease_cause0302 clinical medicineCost of IllnessEpidemiologyPrevalenceEPIDEMIOLOGY030212 general & internal medicineSettore SECS-P/01 - Economia PoliticaCIRRHOSISmedia_commonddc:616Antiviral Agents/therapeutic useeducation.field_of_studyINJECT DRUGSGastroenterologyHCV INFECTIONvirus diseasesHepatitis CEmigration and ImmigrationDISEASE BURDENHepatitis CMarkov ChainsEmigration and Immigration/statistics & numerical data030211 gastroenterology & hepatologyViral hepatitisModelling ; Eradication ; European Union ; Hepatitis C ; prevalenceCOUNTRIESmedicine.medical_specialtyHepatitis C virusPopulationUNITED-STATESWorld Health OrganizationAntiviral Agents03 medical and health sciencesSDG 3 - Good Health and Well-beingPEOPLEInternal medicineIntervention (counseling)medicineJournal Articlemedia_common.cataloged_instanceHumansEuropean UnionViremiaEuropean unionDisease EradicationeducationHepatitis C/diagnosis/drug therapy/epidemiology/prevention & controlHepatologybusiness.industryViremia/diagnosis/drug therapy/epidemiology/prevention & controlHepatologymedicine.diseaseVirologyPREVENTIONdigestive system diseasesHuman medicineVIRAL-HEPATITISbusinessLancet Gastroenterology & Hepatology
researchProduct

Register and clinical follow-up of patients with Peutz-Jeghers syndrome in Valencia

2020

Introduction and aims: Peutz-Jeghers syndrome is a rare autosomal dominant inherited disease caused by a germline mutation of the STK11/LKB1 gene, located on chromosome 19p13.3. It is characterized by mucocutaneous hyperpigmentation, hamartomatous polyposis, and predisposition to cancer. The aim of the present study was to identify and register patients with Peutz-Jeghers syndrome, describe the disease, and estimate its prevalence in Valencia (Spain). Materials and methods: A print-out of the clinical histories from 10 hospitals was obtained utilizing the ICD-9 code 759.6 from the Minimum Basic Data Set of Hospital Admissions of the Spanish Ministry of Health and Consumer Affairs. Results: …

Pediatricsmedicine.medical_specialtyAnemiaMucocutaneous zonePrevalencePeutz–Jeghers syndromeDisease03 medical and health sciences0302 clinical medicineCáncer hereditariomedicine030212 general & internal medicinePóliposlcsh:RC799-869business.industrySTK11CancerInvaginationGeneral Medicinemedicine.diseaseBowel obstructionHamartomatosos030228 respiratory systemlcsh:Diseases of the digestive system. GastroenterologybusinessPeutz JeghersRevista de Gastroenterología de México (English Edition)
researchProduct

Optimizing diagnostic algorithms to advance Hepatitis C elimination in Italy: A cost effectiveness evaluation

2021

Objectives: Optimized diagnostic algorithms to detect active infections are crucial to achieving HCV elimination. We evaluated the cost effectiveness and sustainability of different algorithms for HCV active infection diagnosis, in a context of a high endemic country for HCV infection. Methods: A Markov disease progression model, simulating six diagnostic algorithms in the birth cohort 1969‐1989 over a 10‐year horizon from a healthcare perspective was used. Conventionally diagnosis of active HCV infection is through detection of antibodies (HCV‐Ab) detection followed by HCV‐RNA or HCV core antigen (HCV‐Ag) confirmatory testing either on a second sample or by same sample reflex testing. The …

Pediatricsmedicine.medical_specialtyCost effectivenessCost-Benefit Analysiscost-effectiveneContext (language use)HepacivirusAntiviral AgentsLiver diseaseMedicineHumansbusinesshealth care economics and organizationsHepatologybusiness.industryscreeningDisease progressionHCV chronic infectionvirus diseasesDiagnostic algorithmshealthHepatitis CHepatitis C Chronicmedicine.diseaseHepatitis CHcv eliminationdigestive system diseasesWHO targetHcv core antigenbusinessAlgorithms
researchProduct

Surgical Emergencies in Crohn’s Disease

2015

Crohn’s disease, as a chronic inflammatory disease of unknown etiology that can affect any part of the alimentary canal from the mouth to the anus, has a highly variable course and a very unpredictable evolution. Even surgery does not cure CD, it has however a relevant role in its treatment in combination to medical therapy during the large course of the disease; indeed almost each patient is submitted to a surgical intervention during his life. Nowadays, surgery is considered the last treatment to use whenever medical therapy is insufficient to control symptoms; this choice involves an intervention on more serious patients with more surgical complications. Surgery finds in the Crohn’s dise…

Pediatricsmedicine.medical_specialtyCrohn's diseaseToxic megacolonbusiness.industryMedicine (all)fungifood and beveragesDiseaseAnusmedicine.diseaseShort bowel syndromeChronic inflammatory diseaseGastroenterologydigestive system diseasesmedicine.anatomical_structureInternal medicineAcute appendicitismedicineEtiologybusiness
researchProduct

Nomenclature and diagnosis of gluten-related disorders: A position statement by the Italian Association of Hospital Gastroenterologists and Endoscopi…

2017

Abstract Background “Gluten-related disorders” is a term that encompasses different diseases induced by the ingestion of gluten-containing food. Because of their incidence the scientific community has been intensively studying them. Aim To support gastroenterologists with a correct nomenclature and diagnostic approach to gluten-related disorders in adulthood. Methods The Italian Association of Hospital Gastroenterologists and Endoscopists (AIGO) commissioned a panel of experts to prepare a position statement clarifying the nomenclature and diagnosis of gluten-related disorders, focusing on those of gastroenterological interest. Each member was assigned a task and levels of evidence/recommen…

Pediatricsmedicine.medical_specialtySettore MED/09 - Medicina InternaGlutensNon-celiac gluten sensitivityWheat HypersensitivityDiseaseGastroenterologyDiagnosis DifferentialDiet Gluten-FreeHospital03 medical and health sciences0302 clinical medicineRisk FactorsFood allergyceliac disease; wheat allergy; non-celiac gluten sensitivity; gluten-related disorders; food allergyGluten-related disorderInternal medicineFood allergymedicineHumans030212 general & internal medicineRisk factorSocieties Medicalchemistry.chemical_classificationHepatologybusiness.industryRisk FactorIncidence (epidemiology)BIO/13 - BIOLOGIA APPLICATAGastroenterologynutritional and metabolic diseasesEvidence-based medicinemedicine.diseaseGlutenHospitalsWheat allergydigestive system diseasesCeliac DiseaseItalychemistry030211 gastroenterology & hepatologyDifferential diagnosisbusinessgluten-related disordersGlutenWheat allergyHuman
researchProduct

HAV infection in chronic liver disease: a rationale for vaccination.

2003

We report the conduct and results of a systematic search of the literature to assess whether exposure to HAV could induce a fatal deterioration of liver diseases. We assessed 30 studies and found evidence of progressive decrease of natural immunity against HAV in Italy. HAV vaccine seems as safe in chronic liver diseases than in general population. On the basis of the evidence we recommend that subjects with chronic liver disease should be vaccinated against HAV, especially if younger than 40 years.

Pediatricsmedicine.medical_specialtyvirusesPopulationChronic liver diseaseVirusMedicineHumanseducationeducation.field_of_studyHepatitis A VaccinesGeneral VeterinaryGeneral Immunology and Microbiologybiologybusiness.industryLiver DiseasesfungiPublic Health Environmental and Occupational Healthvirus diseasesbiochemical phenomena metabolism and nutritionHepatitis Abiology.organism_classificationmedicine.diseasedigestive system diseasesVaccinationInfectious DiseasesChronic diseaseImmunologyChronic DiseaseMolecular MedicineViral diseaseHepatovirusbusinessSystematic searchVaccine
researchProduct

Relationship between Helicobacter pylori infection and GERD

2018

Gastroesophageal reflux disease (GERD) is due to the chronic exposure of the esophageal mucosa to acid secretion from the stomach. Helicobacter pylori (H.p.) infection, is a risk factor for the development of peptic ulcer, atrophic gastritis and gastric cancer, and causes various effects on gastric function. The relationship between GERD and H.pylori infection is still subject of debate.Background and aim: In literature no clear causal relationship has been established between GERD and H. pylori infection, although some papers support the onset of esophagitis in patients in whom the infection has been cured. Aim of this work is to review the most recent literature data about the relationshi…

Peptic UlceresophagitisHelicobacter pylorigastroesophageal reflux diseaseSmokingReviewGERDhumanitiesdigestive system diseasesAnti-Bacterial AgentsHelicobacter InfectionsCausalityacid-related disordersStomach NeoplasmsGastritisGastroesophageal RefluxHumansEsophagitis PepticActa bio-medica : Atenei Parmensis
researchProduct

Pressurized intraperitoneal aerosol chemotherapy with cisplatin and doxorubicin or oxaliplatin for peritoneal metastasis from pancreatic adenocarcino…

2020

Background: Systemic chemotherapy for pancreatic adenocarcinoma (PDAC) and cholangiocarcinoma (CC) with peritoneal metastases (PM) is affected by several pharmacological shortcomings and low clinical efficacy. Pressurized intraperitoneal aerosol chemotherapy (PIPAC) is expected to maximize exposure of peritoneal nodules to antiblastic agents. This study aims to evaluate safety and efficacy of PIPAC for PM of PDAC and CC origin. Methods: This is a retrospective analysis of consecutive PDAC and CC cases with PM treated with PIPAC at two European referral centers for peritoneal disease. We prospectively recorded from August 2016 to May 2019 demographic, clinical, surgical, and oncological data…

Peritoneal metastasismedicine.medical_treatmentSettore MED/18 - CHIRURGIA GENERALEpancreatic cancerPIPACcarcinomatosislcsh:RC254-282Pancreatic cancerMedicineDoxorubicincarcinomatosiOriginal ResearchCisplatinChemotherapybusiness.industrySystemic chemotherapyperitoneal metastaseaerosol chemotherapymedicine.diseaselcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogensdigestive system diseasesOxaliplatinperitoneal metastasesOncologyCancer researchlocoregional chemotherapyAdenocarcinomaPIPAC.businesscholangiocarcinomamedicine.drugTherapeutic Advances in Medical Oncology
researchProduct

Immunotherapeutic approaches to inflammatory bowel diseases

2001

For a long time corticosteroids, aminosalicylic acid preparations and antibiotics have represented the principal approaches in evidence-based drug therapy for chronic inflammatory bowel diseases (IBD), e.g., Crohn's disease (CD) and ulcerative colitis (UC), and are able to suppress disease activity in most cases. However, there are cases that do not respond to conventional drug therapy or remain dependent on high doses of steroids associated with severe side effects in the long run. It is generally accepted now that IBD has an immunological basis and results from a hyperresponsive state of the intestinal immune system. Although the primary etiological defect respectively immunogenic agent s…

PharmacologyAminosalicylic acidbusiness.industrymedicine.drug_classClinical BiochemistryAntibioticsDiseaseInflammatory Bowel Diseasesmedicine.diseaseInflammatory bowel diseaseUlcerative colitisdigestive system diseasesMicechemistry.chemical_compoundPharmacotherapyImmune systemchemistryDrug DiscoveryImmunologyEtiologyAnimalsHumansMedicineImmunotherapybusinessExpert Opinion on Biological Therapy
researchProduct